Genentech. Has a futuristic ring to it, doesn’t it? Yet, for more than 35 years, Genentech, Inc., has been known as one of the world’s leading biotechnology companies. Focused primarily on cardiology and oncology, it keeps the door open to “opportunistic” projects where the company has the potential to fill a void in other significant areas of medicine.
About the Author
The Ken Blanchard Companies is the global leader in management training. For more than 35 years, Blanchard has been creating the best managers in the world, training over 150,000 people per year.More Content by The Ken Blanchard Companies